Add BrightSurf on Google Email

Computer-designed protein targets immune receptor linked to inflammation at a new “undruggable” site

Scientists at Scripps Research engineered a synthetic protein that can bind to TLR4 within cell membranes, reducing inflammatory signals. The study advances understanding of TLR4's membrane-embedded region, which is critical for cross-membrane signaling, and outlines new computational tools for targeting proteins within membranes.

SourceScripps Research Institute·JournalProceedings of the National Academy of Sciences·DateOct 1, 2026

ILC2 cells emerge as key cellular interfaces bridging nervous and immune systems

Group 2 innate lymphoid cells (ILC2s) form tight anatomical associations with sensory, autonomic, and enteric nerve fibers, receiving neural regulation through activating and inhibitory pathways. ILC2s also secrete cytokines that can act back on neurons, forming positive feedback loops that modulate allergic and anti-infective immunity.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateSep 25, 2026

AI model uses routine imaging to identify patients at risk for serious treatment-induced lung inflammation

Researchers developed an AI model that uses routine chest CT scans to identify patients at risk of pneumonitis, a potentially life-threatening form of lung inflammation. The model, called CIPHER, achieved high predictive power and maintained strong performance despite differences in patient populations and imaging protocols.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalJournal for ImmunoTherapy of Cancer·DateSep 24, 2026

Target identified in treatment of neuroHIV

A new study by UC Riverside scientists has identified MAPK14, a brain protein, as the driving force behind neuroHIV damage, which causes dementia, neuropathy, and memory problems. By targeting this protein, researchers hope to develop a treatment for neuroHIV, a condition affecting millions worldwide.

SourceUniversity of California - Riverside·JournalBrain Behavior and Immunity·TypeExperimental study·DateSep 22, 2026

‘Invisible’ inflammation in rare bowel disease may explain heightened colon cancer risk

Researchers have mapped cellular differences between two similar bowel diseases, identifying hidden immune activity that may explain why one carries a much higher risk of colon cancer. The study found that patients with PSC-associated IBD had a distinct microbiome and higher levels of immune activity even in the absence of inflammation.

SourceGarvan Institute of Medical Research·JournalNature Communications·TypeObservational study·DateSep 21, 2026

Osteoarthritis: New players involved in joint inflammation

A recent study published in Cell Death & Differentiation highlights the role of endoplasmic reticulum stress proteins in osteoarthritis, revealing their contribution to inflammation and tissue remodeling. The research identifies a promising protein, PDIA4, which may serve as a therapeutic target for limiting disease progression.

SourceUniversity of Liège·JournalCell Death and Differentiation·DateAug 31, 2026

Tissue 'glue' also helps swallow dead cells

A protein that sticks cells together has been found to also help engulf dead cells, a discovery that could lead to new clues for understanding chronic inflammatory conditions. The study found that the 'tissue glue' helps cells adapt to swallow dead cells, which are a major cause of inflammation.

SourceCenter for Genomic Regulation·JournalNature Communications·TypeExperimental study·DateAug 27, 2026

New uOttawa study suggests gene linked to Parkinson's disease holds clues to battling deadly bacterial infections

Researchers have discovered a gene linked to Parkinson's disease may also strengthen the body's ability to fight dangerous infections. The study found that a well-studied mutation in the LRRK2 gene increases the production of reactive oxygen species, making immune cells more effective at eliminating intracellular bacteria.

SourceUniversity of Ottawa·JournalCellular and Molecular Immunology·TypeImaging analysis·DateAug 19, 2026

Flexing new hope: Muscles may help protect the Parkinson's brain

Researchers found that exercise-induced molecular changes contribute to neuronal health, improving movement and quality of life in PD patients. Exercise types such as aerobic exercises, resistance training, balance training, and multimodal exercise were found to be helpful in reducing falls, disabilities, and improving brain function.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 7, 2026

Drug reverses autism-like brain changes in adult mice within hours, study finds

Researchers found that a single dose of rapamycin rapidly improved symptoms in adult mice with autism-like changes, reversing abnormal brain signaling and behavior within two hours. The study suggests the adult brain's functional circuitry, not just its physical structure, as a target for future treatment approaches.

SourceUniversity of California - Los Angeles Health Sciences·TypeRandomized controlled/clinical trial·DateJul 23, 2026

Early inflammation signal drives oral cancer development, highlights path for immunoprevention

A study published in Cancer Research identified an immune pathway that promotes the progression of oral precancerous lesions into head and neck squamous cell carcinoma. The researchers found that targeting a key inflammation signal known as interleukin-1 alpha (IL-1α) could help restore immune surveillance and prevent high-risk lesions...

Scientists discover how macrophages – a key type of immune cells – age differently throughout the body

A new study reveals that macrophages, a key immune cell type, age differently across tissues and between sexes. The researchers found that aging macrophages become more focused on responding to stress and cellular damage, but lose some molecular programs involved in maintaining healthy tissue structure.

SourceUniversity of Southern California·JournalBMC Biology·TypeExperimental study·DateJul 14, 2026

NF-κB signaling pathway: a central hub in the pathogenesis and therapeutic targeting of immunological diseases

The NF-κB signaling pathway plays a central role in pathogenesis and therapeutic targeting of immunological diseases. Dysregulation underpins many conditions, making it a crucial target for treatment. Emerging concepts like ubiquitin code editing and spatial immunology hold promise but require experimental validation.

SourceXia & He Publishing Inc.·JournalGene Expression·DateJul 13, 2026

A pilot clinical trial led by Germans Trias provides the first clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis

A pilot clinical trial assessed ibuprofen's safety and efficacy as an adjunct to standard TB treatment in patients with pre-XDR-TB and XDR-TB. Participants showed a reduced inflammatory response, indicating potential benefits for host-directed therapies.

SourceGermans Trias i Pujol Research Institute·JournalNature Communications·TypeRandomized controlled/clinical trial·DateJul 13, 2026

Macrophages take center stage in organ transplantation: from chronic rejection mechanisms to targeted therapies

Macrophages are critical drivers of chronic allograft failure, with emerging strategies targeting key macrophage signaling pathways providing an important conceptual shift. Targeted therapies, such as inhibiting the purinergic pathway and mTOR/NF-κB pathway, show promise in preventing chronic rejection.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateJul 9, 2026

Gut bacteria linked to malnutrition may pass to younger generations

A new study found that specific gut bacteria from children with stunted growth can be passed to their offspring, causing inflammation and damage to the intestinal lining. The researchers identified Campylobacter concisus as a key contributor to this process, which may hold promise for future treatment and prevention strategies.

SourceWashU Medicine·JournalNature Microbiology·TypeExperimental study·DateJul 8, 2026

Study identifies a new cause of age-related inflammation, suggesting promising treatment pathway

A new study has identified a two-protein complex involved in exporting R-loops, which triggers an immune response causing harmful inflammation. The study tested an approved drug called KPT-330 and found significant improvements in inflammation, liver damage, fat gain, muscle loss, and lifespan in preclinical models.

Body clock found to control inflammatory responses in macrophages

Researchers from Kyushu University discovered that the circadian clock protein BMAL1 drives macrophages towards a pro-inflammatory M1 state by activating inflammatory signaling pathways. This mechanism links the body clock to intracellular metabolism and immune function, offering new insights into treating inflammatory diseases.

SourceKyushu University·JournalCell Reports·TypeExperimental study·DateJun 11, 2026

A study led by IGTP identifies a key mechanism regulating the anti-inflammatory function of extracellular vesicles

Researchers at IGTP identify N-glycosylation as essential for preserving immunomodulatory function of extracellular vesicles. The study found that intact N-glycosylation can reduce monocyte recruitment to inflamed endothelium, contributing to a better understanding of these vesicles' therapeutic potential.

SourceGermans Trias i Pujol Research Institute·JournalJournal of Extracellular Vesicles·TypeExperimental study·DateJun 9, 2026